GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 287 filers reported holding GW PHARMACEUTICALS PLC in Q1 2020. The put-call ratio across all filers is 1.86 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $2,557,000 | -61.9% | 22,160 | -67.9% | 0.07% | -70.5% |
| Q3 2020 | $6,715,000 | -11.8% | 68,980 | +11.2% | 0.25% | -25.1% |
| Q2 2020 | $7,611,000 | +61.8% | 62,020 | +15.4% | 0.34% | +22.3% |
| Q1 2020 | $4,705,000 | -28.5% | 53,730 | -14.6% | 0.27% | +3.4% |
| Q4 2019 | $6,578,000 | -3.2% | 62,910 | +6.5% | 0.26% | -14.8% |
| Q3 2019 | $6,793,000 | -28.4% | 59,050 | +7.2% | 0.31% | -26.1% |
| Q2 2019 | $9,492,000 | +51.2% | 55,060 | +47.8% | 0.42% | +52.5% |
| Q1 2019 | $6,279,000 | +108.2% | 37,250 | +20.3% | 0.28% | +76.9% |
| Q4 2018 | $3,016,000 | -49.4% | 30,970 | -10.2% | 0.16% | -39.3% |
| Q3 2018 | $5,958,000 | +84.3% | 34,490 | +48.9% | 0.26% | +87.6% |
| Q2 2018 | $3,233,000 | – | 23,170 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management, LLC | 311,853 | $25,213,000 | 11.33% |
| Iguana Healthcare Management, LLC | 50,000 | $4,043,000 | 2.16% |
| Ghost Tree Capital, LLC | 35,000 | $2,830,000 | 1.54% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 354,278 | $28,643,000 | 1.06% |
| Cupps Capital Management, LLC | 100,213 | $8,102,000 | 0.75% |
| CLOUGH CAPITAL PARTNERS L P | 192,600 | $15,572,000 | 0.58% |
| FARALLON CAPITAL MANAGEMENT LLC | 244,000 | $19,727,000 | 0.32% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 105,200 | $8,505,000 | 0.31% |
| Eventide Asset Management | 25,000 | $2,021,000 | 0.28% |
| PRUDENTIAL PLC | 836,124 | $67,601,000 | 0.28% |